The United Laboratories International Holdings Limited and Novo Nordisk (NVO) announced earlier that Novo Nordisk and TUL’s wholly-owned ...

Berenberg analyst Kerry Holford lowered the firm’s price target on Novo Nordisk (NVO) to DKK 610 from DKK 725 and keeps a Hold rating on the ...

LONDON, March 24 (Reuters) - German software company SAP (SAPG.DE), opens new tab overtook Danish healthcare company Novo Nordisk (NOVOb.CO), opens new tab as Europe's largest company by market ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British Pharmaceutical Industry (ABPI) has reinstated the Danish drugmaker after seeing ...

Novo Nordisk shares gained Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

Meanwhile, Novo Nordisk shares in Copenhagen closed 1.34% lower, taking the company’s market value just under 2.33 trillion Danish kroner ($337.79 billion).

Novo Nordisk's hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after a series of trial results sent shares falling. Headline results from a ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks that market experts are talking about these days. Piper Sandler’s Chief Market ...

Novo Nordisk regained full ABPI membership after audits confirmed compliance with governance and promotional standards. The company was suspended in 2023 over a complaint alleging inducements to ...

Novo Nordisk received a boost from a bullish analyst note. The company also continues to be the pacesetter in the limited market for weight-loss drugs. That gravity-defying boost was due in no ...

The largest absolute detractors were ICON plc, Novo Nordisk, and L’Oreal. Recent trial results for Novo Nordisk’s next gen GLP-1, Cagrisema, came in below market expectations, sending the ...